Laos Out-Of-Pocket Costs: an Observational Study on the Impact of Severe Childhood Illness on the Health, Wealth and Wellbeing of Household Members in Laos (LOOP)

September 6, 2023 updated by: Murdoch Childrens Research Institute

Laos Out-Of-Pocket Costs: an Observational Study on the Impact of Severe Childhood Illness on the Health, Wealth and Wellbeing of Household Members in Lao People's Democratic Republic

This will be a prospective longitudinal study of children attending hospital for treatment of a severe illness with community follow-up in Lao People's Democratic Republic (Lao PDR). The study aims to summarise and describe short-term health and economic impacts of a severe childhood illness requiring hospital admission, from a household perspective.

Study Overview

Detailed Description

This study aims to measure the out-of-pocket (OOP) expenses for households related to a severe acute illness/injury in children under five years presenting to hospitals in Lao PDR. Financial protection will be measured by determining proportions of households led to catastrophic health expenditures and impoverishment from OOP expenses, with further equity analyses across wealth quintiles, geographical residence, sex, parental education and ethnic subpopulations. Physical health and mental wellbeing outcomes of participants and household members will also be assessed to determine the multifaceted impact of severe childhood disease on a household.

Participants will be recruited in outpatients, the emergency department (ED) or during hospital admission. Information on the participant's illness will be collected through health records where available. Household demographic data, financial costs and coping strategies associated with illness and health/wellbeing outcomes will be collected through parent/caregiver structured questionnaires. These will be conducted during presentation to outpatients/ED or during admission on the wards, with follow-up at 2 weeks and at 2 months post-presentation or post-discharge.

Average total household out-of-pocket (OOP) expenses associated with the illness will be presented for the study population. An equity analysis will be performed by disaggregating and comparing mean/median OOP costs across wealth quintiles, sex, geographical location, parental education and ethnic groups.

Study Type

Observational

Enrollment (Estimated)

375

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 15 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Children aged between 1 month - 14 years 11 months with a "severe" illness/injury who is admitted or presented to outpatient/ED/ward at one of the participating study site hospitals in Lao PDR.

Description

Inclusion Criteria:

  • Child is aged between 1 month -14 years 11 months at the time of admission/presentation to outpatient / ED / hospital
  • Child presents to or is admitted to hospital at one of the participating study site hospitals within the time period of the study
  • Child presents with symptoms of acute illness that started within the last 2 weeks (14 days) prior to hospital presentation. This will include children with a chronic illness but with new onset of symptoms within last 2 weeks.
  • Child is assessed by a health officer at the participating study site hospital and is deemed to have a "severe" illness/injury. A "severe" illness/injury will be defined as a child showing any emergency signs as outlined in the WHO Pocketbook, second edition:

OR Requires hospital admission/transfer to another health facility for further investigations and/or treatment for their acute illness/injury that cannot be performed in an outpatient setting or ED. This may include but is not limited to: transfer to another hospital with intensive care unit (ICU), intravenous (IV) medication or fluids; enteral nutrition; oxygen therapy; surgery.

• Parent/guardian has provided written informed consent, and will be available for the duration of the study follow-up period.

Exclusion Criteria:

  • Child <1 month or >14 years 11 months at time of presentation to hospital
  • Child with symptoms that started >2 weeks (>14 days) prior to hospital presentation
  • Child admitted to the neonatal intensive care unit (NICU)
  • Child admitted to hospital for a planned procedure or planned treatment of a chronic medical condition (eg. Tonsillectomy, replacement of ventriculoperitoneal shunt or percutaneous endoscopic gastronomy (PEG) tube, tune up for cystic fibrosis, chemotherapy, palliative care),
  • Child already enrolled into this study from a previous hospital admission
  • Child discharged prior to screening and informed consent processes by study team members.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children aged 1 month - 14 years 11 months with a severe illness/injury
Children aged 1 month - 14 years 11 months presenting to hospital with symptoms of an acute "severe" illness/injury that started within the last 2 weeks. "Severe" defined as a child showing emergency signs or requiring hospital admission for treatment.
This is an observational study with no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean total out-of-pocket (OOP) expenses
Time Frame: 2 months

Total OOP expenses are the combined total of direct (medical and non-medical) OOP expenses and indirect costs per household.

Data will be collected from a parent/guardian questionnaire developed for the study and expenses will be calculated from onset of symptoms up to 2 months post-discharge from hospital; presented in Lao kip (LAK) and US dollars (USD). Outcome will be presented as mean total OOP expenses per household.

Direct medical OOP costs include: consultation fees, fees for diagnostics, medicine and other treatment/remedy costs, hospital bed fees, transfer costs, insurance co-pay if applicable.

Direct non-medical OOP costs include: travel costs for patient and accompanying carer/household member/s, daily living expenses for patient and accompanying carer/household member/s including food, childcare costs for other children at home, lodging.

Indirect costs include: travel time, loss of income incurred from the cessation or reduction of work productivity.

2 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total number and percentage of households experiencing Catastrophic Health Expenditure (CHE) set at 10% total annual household expenditure (CHE10a)
Time Frame: 2 months

CHE: defined as when the total OOP expenses exceeds a threshold proportion of household expenditures.

CHE10a: The primary CHE threshold will be set at 10% of total annual household expenditure to align with Sustainable Development Goal (SDG) indicator 3.8.2.

OOP expenses and household expenditures will be collected through a study developed questionnaire and CHE10a will be presented as a total number and as a percentage of study participants.

2 months
Total number and percentage of households experiencing CHE set at 10% monthly household expenditure (CHE10m)
Time Frame: 2 months
CHE10m: a secondary CHE threshold will be set at 10% of monthly household expenditure to show the immediate financial impact of the illness OOP expenses and household expenditures will be collected through a study developed questionnaire and CHE10m will be presented as a total number and as a percentage of study participants.
2 months
Total number and percentage of households experiencing CHE set at 40% annual capacity to pay (CHE40a)
Time Frame: 2 months

CHE40a: a secondary CHE threshold will be set at 40% annual capacity to pay (CTP) with previous studies suggesting it more effective at identifying poorer households.

CTP: defined as the total household expenditures minus necessary subsistence expenditures (food, housing, utilities).

OOP expenses and household expenditures will be collected through a study developed questionnaire and CHE40a will be presented as a total number and as a percentage of study participants.

2 months
Total number and percentage of households experiencing CHE set at 40% monthly CTP (CHE40m)
Time Frame: 2 months

CHE40m: a secondary CHE threshold will be set at 40% monthly CTP with previous studies suggesting it more effective at identifying poorer households.

CTP: defined as the total household expenditures minus necessary subsistence expenditures (food, housing, utilities).

OOP expenses and household expenditures will be collected through a study developed questionnaire and CHE40m will be presented as a total number and as a percentage of study participants.

2 months
Total number and percentage of households experiencing Impoverishment Health Expenditure (IHE) set at international poverty line (IHE-i)
Time Frame: 2 months

IHE: defined as households that fall below the poverty line due to the OOP payments associated with the severe illness.

IHE-i: primary threshold will be presented for the international poverty line (US$1.90 per person per day) to align with SDG target 1.1.

OOP expenses will be collected through a study developed questionnaire and IHE-i will be presented as a total number and as a percentage of study participants.

2 months
Total number and percentage of households experiencing Impoverishment Health Expenditure (IHE) set at national poverty line (IHE-n)
Time Frame: 2 months
IHE-n: a secondary threshold will be presented for the national poverty line (LAK 280,910 per person per month) OOP expenses will be collected through a study developed questionnaire and IHE-n will be presented as a total number and as a percentage of study participants.
2 months
Median number of coping strategies used by households
Time Frame: 2 months

Strategies households employ to finance the OOP costs related to the severe illness, defined as: use of savings, borrowing, help from others, asset sales, delayed plans, and/or reduced consumption.

Data will be collected through a study developed questionnaire and will be presented as median number of coping strategies used per household.

2 months
Health outcomes of participating children - mean length of hospital admission
Time Frame: 2 months
Length of hospital admission measured in days Data will be collected from participants' hospital medical records and will be presented as mean length of hospital admission per participant.
2 months
Health outcome of participating children - total number and percentage of deaths
Time Frame: 2 months

Total number of deaths of participating children during study period, presented as total number and percentage of study population.

Data will be collected from parent/guardian report in study developed questionnaire

2 months
Health outcome of participating children - total number and percentage of participating children reporting each recovery status
Time Frame: at 2 weeks post-discharge from hospital
Recovery status defined as level of recovery from serious illness as reported by parent/guardian (full recovery, partial recovery, sicker than when left hospital, death). Recovery status will be presented as total number and percentage of study population reporting each recovery status and then ranked from highest to lowest percentage. Data will be collected from a study developed questionnaire
at 2 weeks post-discharge from hospital
Health outcome of participating children - total number and percentage of participating children reporting each recovery status
Time Frame: at 2 months post-discharge from hospital
Recovery status defined as level of recovery from serious illness as reported by parent/guardian (full recovery, partial recovery, sicker than when left hospital, death). Recovery status will be presented as total number and percentage of study population reporting each recovery status and then ranked from highest to lowest percentage. Data will be collected from a study developed questionnaire
at 2 months post-discharge from hospital
Health outcome of participating children - total number of children returning to ED/hospital
Time Frame: 2 months

Total number of participating children returning to ED/hospital as a complication of the initial severe illness.

Data will be collected from parent/guardian report in study developed questionnaire and will be presented as total number and as percentage of study population.

2 months
Health outcome of participating children - mean change in nutritional status
Time Frame: 2 months

Change in nutritional status defined as change in weight-for-height score presented as standard deviation (or z-score) from outpatient/ED presentation or hospital discharge. The z-score are compared to reference population z-scores as defined in WHO global database growth charts.

Data will be collected through anthropometry measures (height and weight) and will be presented as mean difference in z-score for study population from start to end of study period.

2 months
Health outcome of participating children - total number and percentage with moderate to severe wasting
Time Frame: At enrolment (day 0)

Number of participants with wasting defined as weight-for-height score presented as standard deviation <-2 (z-score <-2).

Data will be collected through anthropometry measures (height and weight) and will be presented as total number and as percentage of study population.

At enrolment (day 0)
Health outcome of participating children - total number and percentage with moderate to severe wasting
Time Frame: 2 months
Number of participants with wasting defined as weight-for-height z-score <-2. Data will be collected through anthropometry measures (height and weight) and will be presented as total number and as percentage of study population.
2 months
Health outcome of participating children - total number and percentage of children not admitted to hospital or early discharge from hospital
Time Frame: 2 months

Total number of participants with patient/caregiver decision to not be admitted to hospital from outpatients/ED or discharge early from hospital against medical advice.

Data will be collected from parent/guardian report in study developed questionnaire or participants' hospital medical records and will be presented as total number as percentage of study population.

2 months
Health and wellbeing outcomes of participant household members - median number of household members with same illness as participant child
Time Frame: 2 months
Number of household members with same illness as participant. Data will be collected from parent/guardian report in study developed questionnaire and presented as median number of sick household members per household.
2 months
Health and wellbeing outcomes of participant household members - median number of deaths
Time Frame: 2 months

Number of deaths of household members within each household during study period.

Data will be collected from parent/guardian report in study developed questionnaire and presented as median number of deaths of household members per household.

2 months
Health and wellbeing outcomes of primary caregivers - total number and percentage of primary caregivers with worse nutritional status
Time Frame: 2 months

Primary caregivers with worse nutritional status, defined as unintentional weight loss of >5% from recruitment stage; and/or primary caregivers that are pushed into category of underweight (BMI < 18 kg/m2) from recruitment stage.

Data will be collected from anthropometry measures (height and weight) of primary caregivers and will be presented as total number and as a percentage of primary caregivers.

2 months
Health and wellbeing outcomes of primary caregiver - mean change in quality of life score (physical health)
Time Frame: 2 months

The WHO Quality of Life - abbreviated version tool (WHOQOL-BREF) is a short-version of the WHOQOL-100, a validated tool developed by WHO to assess quality of life. The WHOQOL-BREF is a 26-item questionnaire assessing four domains contributing to quality of life (physical health, psychological health, social relationships, environment). Each domain will produce a score from 0-100, with a higher score indicating a higher quality of life for that domain.

The WHOQOL-BREF questionnaire will be conducted with the primary caregiver. Score for the physical health domain will be presented as mean difference in scores from start to end of study period.

2 months
Health and wellbeing outcomes of primary caregiver - mean change in quality of life score (psychological health)
Time Frame: 2 months

The WHO Quality of Life - abbreviated version tool (WHOQOL-BREF) is a short-version of the WHOQOL-100, a validated tool developed by WHO to assess quality of life. The WHOQOL-BREF is a 26-item questionnaire assessing four domains contributing to quality of life (physical health, psychological health, social relationships, environment). Each domain will produce a score from 0-100, with a higher score indicating a higher quality of life for that domain.

The WHOQOL-BREF questionnaire will be conducted with the primary caregiver. Score for the psychological health domain will be presented as mean difference in scores from start to end of study period.

2 months
Health and wellbeing outcomes of primary caregiver - mean change in quality of life score (social relationships)
Time Frame: 2 months

The WHO Quality of Life - abbreviated version tool (WHOQOL-BREF) is a short-version of the WHOQOL-100, a validated tool developed by WHO to assess quality of life. The WHOQOL-BREF is a 26-item questionnaire assessing four domains contributing to quality of life (physical health, psychological health, social relationships, environment). Each domain will produce a score from 0-100, with a higher score indicating a higher quality of life for that domain.

The WHOQOL-BREF questionnaire will be conducted with the primary caregiver. Score for the social relationships domain will be presented as mean difference in scores from start to end of study period.

2 months
Health and wellbeing outcomes of primary caregiver - mean change in quality of life score (environment)
Time Frame: 2 months

The WHO Quality of Life - abbreviated version tool (WHOQOL-BREF) is a short-version of the WHOQOL-100, a validated tool developed by WHO to assess quality of life. The WHOQOL-BREF is a 26-item questionnaire assessing four domains contributing to quality of life (physical health, psychological health, social relationships, environment). Each domain will produce a score from 0-100, with a higher score indicating a higher quality of life for that domain.

The WHOQOL-BREF questionnaire will be conducted with the primary caregiver. Score for the environment domain will be presented as mean difference in scores from start to end of study period.

2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fiona Russell, BMBS FRACP MPHTM PhD, Murdoch Children's Research Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2022

Primary Completion (Estimated)

February 1, 2024

Study Completion (Estimated)

February 1, 2024

Study Registration Dates

First Submitted

February 3, 2022

First Submitted That Met QC Criteria

February 3, 2022

First Posted (Actual)

February 14, 2022

Study Record Updates

Last Update Posted (Actual)

September 8, 2023

Last Update Submitted That Met QC Criteria

September 6, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Beginning 0 (zero) months following analysis and article publication, individual participant data (IPD) will be made available long-term for use by future researchers from a recognised research institution whose proposed use of the data has been ethically reviewed and approved by an independent committee and who accept MCRI's conditions for access.

• Individual participant data that underlie the results reported in this article after de-identification (text, tables, figures, and appendices) will be made available

IPD Sharing Time Frame

Will be available from date summary data is published

IPD Sharing Access Criteria

Requests to access IPD are to be made with the principal investigator who will review requests and share IPD with supporting information as ethically appropriate. All IPD will be de-identified

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Health

Clinical Trials on No intervention

3
Subscribe